Tryp Therapeutics Inc.
TRYPF · OTC
8/31/2023 | 8/31/2022 | 8/31/2021 | 8/31/2020 | |
|---|---|---|---|---|
| Market Cap | $7 | $14 | $31 | $39 |
| - Cash | $0 | $2 | $4 | $1 |
| + Debt | $2 | $0 | $0 | $0 |
| Enterprise Value | $8 | $12 | $27 | $38 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$5 | -$7 | -$6 | $0 |
| % Margin | – | – | – | – |
| Net Income | -$5 | -$7 | -$8 | -$0 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.055 | -0.096 | -0.12 | -0.011 |
| % Growth | 43.1% | 20% | -990.9% | – |
| Operating Cash Flow | -$4 | -$6 | -$5 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$4 | -$6 | -$5 | -$0 |